{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T20:18:56Z","timestamp":1783455536543,"version":"3.55.0"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T00:00:00Z","timestamp":1774569600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T00:00:00Z","timestamp":1774569600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100007210","name":"RWTH Aachen University","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100007210","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Nucl Med Mol Imaging"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1007\/s00259-026-07773-x","type":"journal-article","created":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T00:35:15Z","timestamp":1774571715000},"page":"4850-4861","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Diagnostic accuracy of PSMA-targeted radioguided surgery in prostate cancer at multiple anatomical levels: a systematic review and meta-analysis"],"prefix":"10.1007","volume":"53","author":[{"given":"Fang","family":"Wen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Sch\u00e4fer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinlin","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Walter","family":"Noordzij","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias","family":"Saar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felix M.","family":"Mottaghy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susanne","family":"L\u00fctje","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,27]]},"reference":[{"key":"7773_CR1","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71:209\u201349. https:\/\/doi.org\/10.3322\/caac.21660.","journal-title":"CA Cancer J Clin"},{"key":"7773_CR2","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.eururo.2024.03.027","volume":"86","author":"P Cornford","year":"2024","unstructured":"Cornford P, van den Bergh RCN, Briers E, Van den Broeck T, Brunckhorst O, Darraugh J, et al. EAU-EANM-ESTRO-ESUR-ISUP-SIOG guidelines on prostate cancer-2024 update. Part I: screening, diagnosis, and local treatment with curative intent. Eur Urol. 2024;86:148\u201363. https:\/\/doi.org\/10.1016\/j.eururo.2024.03.027.","journal-title":"Eur Urol"},{"key":"7773_CR3","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1016\/j.eururo.2024.04.010","volume":"86","author":"D Tilki","year":"2024","unstructured":"Tilki D, Bergh R, Briers E, van den Broeckf T, Brunckhorstg O, Darraugh J, et al. EAU-EANM-ESTRO-ESUR-ISUP-SIOG guidelines on prostate cancer. Part II-2024 update: treatment of relapsing and metastatic prostate cancer. Eur Urol. 2024;86:164\u201382. https:\/\/doi.org\/10.1016\/j.eururo.2024.04.010.","journal-title":"Eur Urol."},{"key":"7773_CR4","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.1056\/NEJMoa1606220","volume":"375","author":"FC Hamdy","year":"2016","unstructured":"Hamdy FC, Donovan JL, Lane JA, Mason M, Metcalfe C, Holding P, et al. 10-year outcomes after monitoring, surgery, or radiotherapy for localized prostate cancer. N Engl J Med. 2016;375:1415\u201324. https:\/\/doi.org\/10.1056\/NEJMoa1606220.","journal-title":"N Engl J Med"},{"key":"7773_CR5","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0301653","volume":"19","author":"H Guo","year":"2024","unstructured":"Guo H, Zhang L, Shao Y, An K, Hu C, Liang X, et al. The impact of positive surgical margin parameters and pathological stage on biochemical recurrence after radical prostatectomy: a systematic review and meta-analysis. PLoS One. 2024;19:e0301653. https:\/\/doi.org\/10.1371\/journal.pone.0301653.","journal-title":"PLoS One"},{"key":"7773_CR6","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.euf.2018.09.014","volume":"5","author":"S Knipper","year":"2019","unstructured":"Knipper S, Tilki D, Mansholt J, Berliner C, Bernreuther C, Steuber T, et al. Metastases-yield and prostate-specific antigen kinetics following salvage lymph node dissection for prostate cancer: a comparison between conventional surgical approach and prostate-specific membrane antigen-radioguided surgery. Eur Urol Focus. 2019;5:50\u20133. https:\/\/doi.org\/10.1016\/j.euf.2018.09.014.","journal-title":"Eur Urol Focus"},{"key":"7773_CR7","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1097\/mou.0000000000000688","volume":"30","author":"P Dell\u2019Oglio","year":"2020","unstructured":"Dell\u2019Oglio P, Mottrie A, Mazzone E. Robot-assisted radical prostatectomy vs. open radical prostatectomy: latest evidences on perioperative, functional and oncological outcomes. Curr Opin Urol. 2020;30:73\u20138. https:\/\/doi.org\/10.1097\/mou.0000000000000688.","journal-title":"Curr Opin Urol"},{"key":"7773_CR8","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2023.115966","volume":"263","author":"G Capasso","year":"2024","unstructured":"Capasso G, Stefanucci A, Tolomeo A. A systematic review on the current status of PSMA-targeted imaging and radioligand therapy. Eur J Med Chem. 2024;263:115966. https:\/\/doi.org\/10.1016\/j.ejmech.2023.115966.","journal-title":"Eur J Med Chem"},{"key":"7773_CR9","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1038\/nrc882","volume":"2","author":"SS Gambhir","year":"2002","unstructured":"Gambhir SS. Molecular imaging of cancer with positron emission tomography. Nat Rev Cancer. 2002;2:683\u201393. https:\/\/doi.org\/10.1038\/nrc882.","journal-title":"Nat Rev Cancer"},{"key":"7773_CR10","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1016\/j.eururo.2018.03.013","volume":"75","author":"T Maurer","year":"2019","unstructured":"Maurer T, Robu S, Schottelius M, Schwamborn K, Rauscher I, van den Berg NS, et al. (99m)technetium-based prostate-specific membrane antigen-radioguided surgery in recurrent prostate cancer. Eur Urol. 2019;75:659\u201366. https:\/\/doi.org\/10.1016\/j.eururo.2018.03.013.","journal-title":"Eur Urol"},{"key":"7773_CR11","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1016\/j.eururo.2019.01.049","volume":"77","author":"M Perera","year":"2020","unstructured":"Perera M, Papa N, Roberts M, Williams M, Udovicich C, Vela I, et al. Gallium-68 prostate-specific membrane antigen positron emission tomography in advanced prostate cancer-updated diagnostic utility, sensitivity, specificity, and distribution of prostate-specific membrane antigen-avid lesions: a systematic review and meta-analysis. Eur Urol. 2020;77:403\u201317. https:\/\/doi.org\/10.1016\/j.eururo.2019.01.049.","journal-title":"Eur Urol"},{"key":"7773_CR12","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1111\/bju.13713","volume":"120","author":"I Rauscher","year":"2017","unstructured":"Rauscher I, D\u00fcwel C, Wirtz M, Schottelius M, Wester HJ, Schwamborn K, et al. Value of (111) in-prostate-specific membrane antigen (PSMA)-radioguided surgery for salvage lymphadenectomy in recurrent prostate cancer: correlation with histopathology and clinical follow-up. BJU Int. 2017;120:40\u20137. https:\/\/doi.org\/10.1111\/bju.13713.","journal-title":"BJU Int"},{"key":"7773_CR13","doi-asserted-by":"publisher","first-page":"2062","DOI":"10.1007\/s00259-018-4094-0","volume":"45","author":"M Mix","year":"2018","unstructured":"Mix M, Reichel K, Stoykow C, Bartholom\u00e4 M, Drendel V, Gourni E, et al. Performance of (111)in-labelled PSMA ligand in patients with nodal metastatic prostate cancer: correlation between tracer uptake and histopathology from lymphadenectomy. Eur J Nucl Med Mol Imaging. 2018;45:2062\u201370. https:\/\/doi.org\/10.1007\/s00259-018-4094-0.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"7773_CR14","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.eururo.2022.03.002","volume":"82","author":"HA de Barros","year":"2022","unstructured":"de Barros HA, van Oosterom MN, Donswijk ML, Hendrikx J, Vis AN, Maurer T, et al. Robot-assisted prostate-specific membrane antigen-radioguided salvage surgery in recurrent prostate cancer using a DROP-IN gamma probe: the first prospective feasibility study. Eur Urol. 2022;82:97\u2013105. https:\/\/doi.org\/10.1016\/j.eururo.2022.03.002.","journal-title":"Eur Urol"},{"key":"7773_CR15","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.euros.2023.05.017","volume":"54","author":"C Darr","year":"2023","unstructured":"Darr C, Costa PF, Kahl T, Moraitis A, Engel J, Al-Nader M, et al. Intraoperative molecular positron emission tomography imaging for intraoperative assessment of radical prostatectomy specimens. Eur Urol Open Sci. 2023;54:28\u201332. https:\/\/doi.org\/10.1016\/j.euros.2023.05.017.","journal-title":"Eur Urol Open Sci"},{"issue":"5","key":"7773_CR16","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1016\/j.euo.2022.05.003","volume":"5","author":"S Fanti","year":"2022","unstructured":"Fanti S, Briganti A, Emmett L, Fizazi K, Gillessen S, Goffin K, et al. EAU-EANM consensus statements on the role of prostate-specific membrane antigen positron emission tomography\/computed tomography in patients with prostate cancer and with respect to [(177)Lu]Lu-PSMA radioligand therapy. Eur Urol Oncol. 2022;5(5):530\u20136. https:\/\/doi.org\/10.1016\/j.euo.2022.05.003.","journal-title":"Eur Urol Oncol"},{"key":"7773_CR17","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1016\/j.eururo.2019.03.045","volume":"76","author":"T Horn","year":"2019","unstructured":"Horn T, Kr\u00f6nke M, Rauscher I, Haller B, Robu S, Wester HJ, et al. Single lesion on prostate-specific membrane antigen-ligand positron emission tomography and low prostate-specific antigen are prognostic factors for a favorable biochemical response to prostate-specific membrane antigen-targeted radioguided surgery in recurrent prostate cancer. Eur Urol. 2019;76:517\u201323. https:\/\/doi.org\/10.1016\/j.eururo.2019.03.045.","journal-title":"Eur Urol"},{"key":"7773_CR18","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.euo.2022.12.001","volume":"6","author":"L Lunger","year":"2023","unstructured":"Lunger L, Steinhelfer L, Korn P, Eiber M, Maurer T, B\u00fcchler J, et al. Prostate-specific membrane antigen\u2013radioguided surgery facilitates pelvic lymph node dissection during radical prostatectomy for the treatment of locally advanced prostate cancer with regional lymph node metastases. Eur Urol Oncol. 2023;6:95\u20138. https:\/\/doi.org\/10.1016\/j.euo.2022.12.001.","journal-title":"Eur Urol Oncol"},{"key":"7773_CR19","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1016\/j.eururo.2015.04.034","volume":"68","author":"T Maurer","year":"2015","unstructured":"Maurer T, Weirich G, Schottelius M, Weineisen M, Frisch B, Okur A, et al. Prostate-specific membrane antigen-radioguided surgery for metastatic lymph nodes in prostate cancer. Eur Urol. 2015;68:530\u20134. https:\/\/doi.org\/10.1016\/j.eururo.2015.04.034.","journal-title":"Eur Urol"},{"key":"7773_CR20","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.b2700","volume":"339","author":"A Liberati","year":"2009","unstructured":"Liberati A, Altman DG, Tetzlaff J, Mulrow C, G\u00f8tzsche PC, Ioannidis JP, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration. BMJ (Clinical research ed). 2009;339:b2700. https:\/\/doi.org\/10.1136\/bmj.b2700.","journal-title":"BMJ (Clinical research ed)"},{"key":"7773_CR21","doi-asserted-by":"publisher","unstructured":"Collamati F, van Oosterom MN, De Simoni M, Faccini R, Fischetti M, Mancini Terracciano C, et al. A DROP-IN beta probe for robot-assisted 68Ga-PSMA radioguided surgery: first ex vivo technology evaluation using prostate cancer specimens. EJNMMI Res. 2020;10. https:\/\/doi.org\/10.1186\/s13550-020-00682-6.","DOI":"10.1186\/s13550-020-00682-6"},{"key":"7773_CR22","doi-asserted-by":"publisher","DOI":"10.1186\/s13550-020-0598-2","volume":"10","author":"CA Jilg","year":"2020","unstructured":"Jilg CA, Reichel K, Stoykow C, Rischke HC, Bartholom\u00e4 M, Drendel V, et al. Results from extended lymphadenectomies with [(111)In]PSMA-617 for intraoperative detection of PSMA-PET\/CT-positive nodal metastatic prostate cancer. EJNMMI Res. 2020;10:17. https:\/\/doi.org\/10.1186\/s13550-020-0598-2.","journal-title":"EJNMMI Res"},{"key":"7773_CR23","doi-asserted-by":"publisher","unstructured":"Mix M, Schultze-Seemann W, von B\u00fcren M, Sigle A, Omrane MA, Grabbert MT, et al. 99mTc-labelled PSMA ligand for radio-guided surgery in nodal metastatic prostate cancer: proof of principle. EJNMMI Res. 2021;11. https:\/\/doi.org\/10.1186\/s13550-021-00762-1.","DOI":"10.1186\/s13550-021-00762-1"},{"key":"7773_CR24","doi-asserted-by":"publisher","unstructured":"Gondoputro W, Scheltema MJ, Blazevski A, Doan P, Thompson JE, Amin A, et al. Robot-assisted prostate-specific membrane antigen-radioguided surgery in primary diagnosed prostate cancer. J Nucl Med. 2022;63:1659\u201364. https:\/\/doi.org\/10.2967\/jnumed.121.263743.","DOI":"10.2967\/jnumed.121.263743"},{"key":"7773_CR25","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.eururo.2022.05.031","volume":"83","author":"S Knipper","year":"2023","unstructured":"Knipper S, Irai MM, Simon R, Koehler D, Rauscher I, Eiber M, et al. Cohort study of oligorecurrent prostate cancer patients: oncological outcomes of patients treated with salvage lymph node dissection via prostate-specific membrane antigen-radioguided surgery. Eur Urol. 2023;83:62\u20139. https:\/\/doi.org\/10.1016\/j.eururo.2022.05.031.","journal-title":"Eur Urol"},{"key":"7773_CR26","doi-asserted-by":"publisher","unstructured":"Y\u0131lmaz B, \u015eahin S, Erg\u00fcl N, \u00c7olakog\u0306lu Y, Baytekin HF, S\u00f6kmen D, et al. 99mTc-PSMA targeted robot-assisted radioguided surgery during radical prostatectomy and extended lymph node dissection of prostate cancer patients. Ann Nucl Med. 2022;36:597\u2013609. https:\/\/doi.org\/10.1007\/s12149-022-01741-9.","DOI":"10.1007\/s12149-022-01741-9"},{"key":"7773_CR27","doi-asserted-by":"publisher","unstructured":"Gandaglia G, Mazzone E, Stabile A, Pellegrino A, Cucchiara V, Barletta F, et al. Prostate-specific membrane antigen radioguided surgery to detect nodal metastases in primary prostate cancer patients undergoing robot-assisted radical prostatectomy and extended pelvic lymph node dissection: results of a planned interim analysis of a prospective phase 2 study. Eur Urol. 2022;82:411\u20138. https:\/\/doi.org\/10.1016\/j.eururo.2022.06.002.","DOI":"10.1016\/j.eururo.2022.06.002"},{"key":"7773_CR28","doi-asserted-by":"publisher","unstructured":"Koehler D, Sauer M, Klutmann S, Apostolova I, Lehnert W, Bud\u00e4us L, et al. Feasibility of 99mTc-MIP-1404 for SPECT\/CT imaging and subsequent PSMA-radioguided surgery in early biochemically recurrent prostate cancer: a case series of 9 patients. J Nucl Med. 2023;64:59\u201362. https:\/\/doi.org\/10.2967\/jnumed.122.263892.","DOI":"10.2967\/jnumed.122.263892"},{"issue":"5","key":"7773_CR29","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1016\/s1470-2045(23)00102-x","volume":"24","author":"JA Stibbe","year":"2023","unstructured":"Stibbe JA, de Barros HA, Linders DGJ, Bhairosingh SS, Bekers EM, van Leeuwen PJ, et al. First-in-patient study of OTL78 for intraoperative fluorescence imaging of prostate-specific membrane antigen-positive prostate cancer: a single-arm, phase 2a, feasibility trial. Lancet Oncol. 2023;24(5):457\u201367. https:\/\/doi.org\/10.1016\/s1470-2045(23)00102-x.","journal-title":"Lancet Oncol"},{"key":"7773_CR30","doi-asserted-by":"publisher","unstructured":"Falkenbach F, Lischewski F, Knipper S, Koehler D, Karakiewicz PI, Tian Z, et al. Prostate-specific membrane antigen\u2013radioguided Surgery in an EMBARK-like cohort of patients with oligorecurrent hormone-sensitive prostate cancer: delay in systemic treatment. Eur Urol focus. 2025. https:\/\/doi.org\/10.1016\/j.euf.2025.01.006.","DOI":"10.1016\/j.euf.2025.01.006"},{"key":"7773_CR31","doi-asserted-by":"publisher","unstructured":"Mayr R, Engelmann SU, Yang YS, Haas M, Schmid T, Schnabel MJ, et al. Prostatespecific membrane antigen-radioguided surgery salvage lymph node dissection: experience with fifty oligorecurrent prostate cancer patients. World J Urol. 2024;42. https:\/\/doi.org\/10.1007\/s00345-024-05189-6.","DOI":"10.1007\/s00345-024-05189-6"},{"key":"7773_CR32","doi-asserted-by":"publisher","unstructured":"Harke NN, Fuhrmann C, Czerner C, Rudolf F, Ross TL, Katzendorn O, et al. Feasibility of using a novel drop-in gamma probe for 99m Tc-PSMA-I&S-guided lymph node detection during robot-assisted radical prostatectomy for primary prostate cancer. Clin Nucl Med. 2024;49:948\u201352. https:\/\/doi.org\/10.1097\/rlu.0000000000005385.","DOI":"10.1097\/rlu.0000000000005385"},{"key":"7773_CR33","doi-asserted-by":"publisher","unstructured":"Quarta L, Mazzone E, Cannoletta D, Stabile A, Scuderi S, Barletta F, et al. Defining the optimal target-to-background ratio to identify positive lymph nodes in prostate cancer patients undergoing robot-assisted [99mTc]Tc-PSMA radioguided surgery: updated results and ad interim analyses of a prospective phase II study. Eur J Nucl Med Mol Imaging. 2024;51:3789\u201398. https:\/\/doi.org\/10.1007\/s00259-024-06789-5.","DOI":"10.1007\/s00259-024-06789-5"},{"key":"7773_CR34","doi-asserted-by":"publisher","unstructured":"Collamati F, Morganti S, van Oosterom MN, Campana L, Ceci F, Luzzago S, et al. First-in-human validation of a DROP-IN \u03b2-probe for robotic radioguided surgery: defining optimal signal-to-background discrimination algorithm. Eur j Nucl Med Mol Imaging. 2024;51:3098\u2013108. https:\/\/doi.org\/10.1007\/s00259-024-06653-6.","DOI":"10.1007\/s00259-024-06653-6"},{"key":"7773_CR35","doi-asserted-by":"publisher","unstructured":"Schilham MGM, Somford DM, K\u00fcsters-Vandevelde HVN, Hermsen R, van Basten JPA, Hoekstra RJ, et al. Prostate-specific membrane antigen\u2013targeted radioguided pelvic lymph node dissection in newly diagnosed prostate cancer patients with a suspicion of locoregional lymph node metastases: the DETECT trial. J Nucl Med. 2024;65:423\u20139. https:\/\/doi.org\/10.2967\/jnumed.123.266495.","DOI":"10.2967\/jnumed.123.266495"},{"key":"7773_CR36","doi-asserted-by":"publisher","unstructured":"Ambrosini F, Falkenbach F, Bud\u00e4us L, Steuber T, Graefen M, Koehler D, et al. Comparative analysis of robot-assisted and open approach for PSMA-radioguided surgery in recurrent prostate cancer. Eur J Nucl Med Mol Imaging. 2024;51:3079\u201388. https:\/\/doi.org\/10.1007\/s00259-023-06460-5.","DOI":"10.1007\/s00259-023-06460-5"},{"key":"7773_CR37","doi-asserted-by":"publisher","unstructured":"Winkens T, Berger FP, Foller S, Greiser J, Groeber S, Grimm MO, et al. 67Ga-PSMA I&T for radioguided surgery of lymph node metastases in patients with biochemical recurrence of prostate cancer. Clin Nucl Med. 2023;48:600\u20137. https:\/\/doi.org\/10.1097\/RLU.0000000000004668.","DOI":"10.1097\/RLU.0000000000004668"},{"key":"7773_CR38","doi-asserted-by":"publisher","unstructured":"Knipper S, Ascalone L, Ziegler B, Hohenhorst JL, Simon R, Berliner C, et al. Salvage surgery in patients with local recurrence after radical prostatectomy. Eur Urol. 2021;79:537\u201344. https:\/\/doi.org\/10.1016\/j.eururo.2020.11.012.","DOI":"10.1016\/j.eururo.2020.11.012"},{"key":"7773_CR39","doi-asserted-by":"publisher","first-page":"1500","DOI":"10.2967\/jnumed.119.240424","volume":"61","author":"C Darr","year":"2020","unstructured":"Darr C, Harke NN, Radtke JP, Yirga L, Kesch C, Grootendorst MR, et al. Intraoperative (68)Ga-PSMA cerenkov luminescence imaging for surgical margins in radical prostatectomy: a feasibility study. J Nucl Med. 2020;61:1500\u20136. https:\/\/doi.org\/10.2967\/jnumed.119.240424.","journal-title":"J Nucl Med"},{"key":"7773_CR40","doi-asserted-by":"publisher","unstructured":"olde Heuvel J, de Wit-van der Veen BJ, van der Poel HG, Bekers EM, Grootendorst MR, Vyas KN, et al. 68Ga-PSMA Cerenkov luminescence imaging in primary prostate cancer: first-in-man series. Eur J Nucl Med Mol imaging. 2020;47:2624\u201332. https:\/\/doi.org\/10.1007\/s00259-020-04783-1.","DOI":"10.1007\/s00259-020-04783-1"},{"key":"7773_CR41","doi-asserted-by":"publisher","unstructured":"Heuvel JO, de Wit-van der Veen BJ, van der Poel HG, van Leeuwen PJ, Bekers EM, Grootendorst MR, et al. Cerenkov luminescence imaging in prostate cancer: not the only light that shines. J Nucl Med. 2022;63:29\u201335. https:\/\/doi.org\/10.2967\/jnumed.120.260034.","DOI":"10.2967\/jnumed.120.260034"},{"key":"7773_CR42","doi-asserted-by":"publisher","unstructured":"Darr C, Fragoso Costa P, Kesch C, Krafft U, P\u00fcllen L, Harke NN, et al. Prostate specific membrane antigen-radio guided surgery using Cerenkov luminescence imagingutilization of a short-pass filter to reduce technical pitfalls. Transl Androl Urol. 2021;10:3972\u201385. https:\/\/doi.org\/10.21037\/tau-20-1141.","DOI":"10.21037\/tau-20-1141"},{"key":"7773_CR43","doi-asserted-by":"publisher","unstructured":"Muraglia L, Mattana F, Travaini LL, Musi G, Bertani E, Renne G, et al. First live-experience session with PET\/CT specimen imager: a pilot analysis in prostate cancer and neuroendocrine tumor. Biomedicines. 2023;11. https:\/\/doi.org\/10.3390\/biomedicines11020645.","DOI":"10.3390\/biomedicines11020645"},{"key":"7773_CR44","doi-asserted-by":"publisher","unstructured":"Moraitis A, Kahl T, Kandziora J, Jentzen W, Kersting D, P\u00fcllen L, et al. Evaluation of surgical margins with intraoperative PSMA PET\/CT and their prognostic value in radical prostatectomy. J Nucl Med. 2025;66:352\u20138. https:\/\/doi.org\/10.2967\/jnumed.124.268719.","DOI":"10.2967\/jnumed.124.268719"},{"key":"7773_CR45","doi-asserted-by":"publisher","unstructured":"Mazzucato G, Falkenbach F, Schmalhofer ML, Shenas F, Cerruto MA, Antonelli A, et al. Robot-Assisted PSMA-Radioguided salvage surgery for oligorecurrent prostate cancer using the novel SENSEI(\u00ae) drop-in gamma probe: correlation of intraoperative measurements to preoperative imaging and final histology. Cancers. 2024;17. https:\/\/doi.org\/10.3390\/cancers17010093.","DOI":"10.3390\/cancers17010093"},{"key":"7773_CR46","doi-asserted-by":"publisher","first-page":"786","DOI":"10.2967\/jnumed.118.219501","volume":"60","author":"TA Hope","year":"2019","unstructured":"Hope TA, Goodman JZ, Allen IE, Calais J, Fendler WP, Carroll PR. Metaanalysis of (68)Ga-PSMA-11 PET accuracy for the detection of prostate cancer validated by histopathology. J Nucl Med. 2019;60:786\u201393. https:\/\/doi.org\/10.2967\/jnumed.118.219501.","journal-title":"J Nucl Med"},{"key":"7773_CR47","doi-asserted-by":"publisher","first-page":"71","DOI":"10.2967\/jnumed.118.212720","volume":"60","author":"M Schottelius","year":"2019","unstructured":"Schottelius M, Wurzer A, Wissmiller K, Beck R, Koch M, Gorpas D, et al. Synthesis and preclinical characterization of the PSMA-targeted hybrid tracer PSMA-I&F for nuclear and fluorescence imaging of prostate cancer. J Nucl Med Off Pub Soc Nucl Med. 2019;60:71\u20138. https:\/\/doi.org\/10.2967\/jnumed.118.212720.","journal-title":"J Nucl Med Off Pub Soc Nucl Med"}],"container-title":["European Journal of Nuclear Medicine and Molecular Imaging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-026-07773-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00259-026-07773-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-026-07773-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T20:57:21Z","timestamp":1781643441000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00259-026-07773-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,27]]},"references-count":47,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["7773"],"URL":"https:\/\/doi.org\/10.1007\/s00259-026-07773-x","relation":{},"ISSN":["1619-7070","1619-7089"],"issn-type":[{"value":"1619-7070","type":"print"},{"value":"1619-7089","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,27]]},"assertion":[{"value":"1 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethical approval was not required as this study was a systematic review and meta-analysis.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was not necessary as this study did not include any human experiments.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"The study does not contain any individual person\u2019s data in any form (including any individual details, images or videos).","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to publish"}},{"value":"The authors declare no potential conflicts of interest.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}}]}}